Potential role for non-HLA-restricted cytotoxic cells in the immune surveillance of acute leukemia
- 1 December 1993
- journal article
- Published by Elsevier in Immunology Letters
- Vol. 39 (1) , 13-15
- https://doi.org/10.1016/0165-2478(93)90158-x
Abstract
No abstract availableKeywords
This publication has 10 references indexed in Scilit:
- Susceptibility of acute myelogenous leukemia blasts to lysis by lymphokine-activated killer (LAK) cells and its clinical relevanceLeukemia Research, 1992
- High-dose recombinant interleukin-2 and acute myeloid leukemias in relapseBlood, 1991
- Possible mechanism of selective killing of myeloid leukemic blast cells by lymphokine-activated killer cellsBlood, 1991
- Inducibility of lymphokine activated killer (LAK) cells in patients with acute myelogenous leukaemia in complete remission and its clinical relevanceBritish Journal of Haematology, 1991
- Biology and clinical relevance of human natural killer cellsBlood, 1990
- Graft-versus-leukemia reactions after bone marrow transplantationBlood, 1990
- Endogenously generated activated killer cells circulate after autologous and allogeneic marrow transplantation but not after chemotherapyBlood, 1989
- Interleukin 2 induction of lymphokine-activated killer (LAK) activity in the peripheral blood and bone marrow of acute leukemia patients. I. Feasibility of LAK generation in adult patients with active disease and in remissionBlood, 1988
- Cytotoxicity of interleukin 2-activated lymphocytes for leukemia and lymphoma cellsBlood, 1986
- NATURAL KILLER CELL ACTIVITY IN HUMAN BONE MARROW RECIPIENTS EARLY REAPPEARANCE OF PERIPHERAL NATURAL KILLER ACTIVITY IN GRAFT-VERSUS-HOST DISEASETransplantation, 1981